Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy.
Duchenne muscular dystrophy is a severe, X-linked muscle wasting disorder caused by the absence of an integral structural protein called dystrophin. This is caused by mutations or deletions in the dystrophin gene which disrupt the reading frame, thereby halting the production of a functional protein...
Main Authors: | Betts, C, Wood, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
NOVEL CELL PENETRATING PEPTIDES FOR SKELETAL AND CARDIAC MUSCLE DELIVERY OF PMO ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
by: Hammond, S, et al.
Published: (2011) -
PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy.
by: Hammond, S, et al.
Published: (2010) -
Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
by: Koo, T, et al.
Published: (2013) -
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
by: Goyenvalle, A, et al.
Published: (2011) -
Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.
by: Wood, M
Published: (2010)